Depolymerized holothurian glycosaminoglycan (DHG) prevents neointimal formation in balloon-injured rat carotid artery

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 27-31

  Igarashi, Masahiko ^a   Takeda, Yuki ^a   Mori, Seijiro ^b   Takahashi, Kentaro ^a   Fuse, Tsunekazu ^c   Yamamura, Mikako ^c   Saito, Yasushi ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY HOSPITAL   (Japan)

Author keywords

carotid neointimal thickening; depolymerized holothurian glycosaminoglycan; percutaneous transluminal coronary angioplasty; rat; smooth muscle cell

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CONTROLLED STUDY; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTICOAGULANTS; BODY WEIGHT; CAROTID ARTERIES; CAROTID ARTERY INJURIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSAMINOGLYCANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; LIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS; TUNICA INTIMA;

EID: 0031047910     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06005-4     Document Type: Article

References (28)

1. Loscalzo J. The relation between atherosclerosis and thrombosis. Circulation 1992;86:95.
2. Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis 1994;24:69.
3. Harker LA, Hanson SR, Runge MS. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 1995;75:12B.
4. Weitz JI. Activation of blood coagulation by plaque rupture: mechanism and prevention. Am J Cardiol 1995;75:18B.
5. Wilcox JN, Hanson SR, Rodriguez J et al. Thrombin receptor expression in vascular lesion formation. Circ Res 1994;75:1029.
6. Clowes AW, Clowes MM, Kocher O, Ropraz P Chaponnier C, Gabbiani O. Arterial smooth muscle cells in vivo: relationship between actin isoform expressions and mitogenesis and their modulation by heparin. J Cell Biol 1988;107:1939.
7. Castellot JJ Jr, Cochran DL, Karnovsky MJ. Effect of heparin on vascular smooth muscle cells I: cell metabolism. J Cell Physiol 1985;124:21.
8. Suzuki N, Kitazato K, Takamatsu J, Saito H. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Thromb Haemost 1991;65:369.
9. Yoshida K, Minami Y. Structure of DHO, a depolymerized olycosaminoglycan from sea cucumber, Stichopusjaponicus. Tetrahedron Lett 1992;33:4959
10. Nagase H, Enjyoji K, Minamiguchi K et al. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III - and haparin cofactor II - independent inhibition of factor X activation by factor IX-factor Villa complex and heparin cofactor II-dependent inhibition of thrombin. Blood 1995;85:1527.
11. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577.
12. Faxon DP Currier JW. Prevention of post-PTCA restenosis. Ann New York Acad Sci 1995;748:419.
13. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1991;75:636.
14. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991;81:1426.
15. Liu MW, Berk BC. Restenosis following coronary angioplasty: role of smooth muscle cell proliferation. Trends Cardiovasc Med 1991;1:107.
16. Ashida S, Sakuma K, Abiko Y. Antithrombotic effects of ticlopidine, acetylsalicylic acid and dipyridamole in vascular shunt model in rats. Thromb Res 1980;17:336.
17. Weksler BB, Pett SB, Alonso D et al. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Eng J Med 1983;308:800.
18. Morishita K, Wada M, Kumada T, Tanaka T, Tomikawa M, Iwamoto M. Effect of ticlopidine and other antithrombotics on the venous thrombosis induced by endothelial damage of jugular vein in rats. Thromb Res 1991;63:373.
19. Takiguchi Y, Wada K, Nakashima M. Comparison of the inhibitory effects of TXA2 receptor antagonist, vapiprost, and other antiplatelet drugs on arterial thrombosis in rats: possible role of TXA2. Thromb Haemost 1992;68:460.
20. Suzuka H, Fujiwara H, Tanaka M, Yoshifusa H, Nakamura Y, Shibata Y. Antithrombic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB) F1 male mice with myocardial infarction and systemic lupus erythematosus. J Cardiovasc Pharmacol 1995;25:9.
21. Aviezer D, Levy E, Safran M et al. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptors. J Biol Chem 1994;269:114.
22. Miyazawa J, Higashiyama S, Kawata S et al. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest 1995;95:404.
23. Bennett MR, Littlewood TD, Hancock DC, Evan GI, Newby AC. Down-regulation of the c-myc protooncogene in inhibition of vascular smooth muscle cell proliferation: a signal for growth arrest?. Biochem J 1994;302:701.
24. Nikkari ST, Jarvelaine HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 1994;144:1348.
25. Moura A, Lam JY, Hebert D et al. Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation. Circulation 1995;92:2299.
26. Volker W, Bohm A, Schmidt A et al. Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin. Arzneimittelforschung 1995;45:546.
27. Caplice NW, West MJ, Campbell GR, Campbell J. Inhibition of human vascular smooth muscle cell growth by heparin. Lancet 1994;344:97.
28. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 1995;91:2972.